Sensyne Health PLC's (LON:SENS) CEO Lord Paul Drayson talks to Proactive London's Katie Pilbeam about 'achieving their primary IPO objective' with a database over 5m records.
This comes after its strategic research agreement with Somerset NHS Foundation Trust which pulls in 1.1mln unique records from a population of 600,000. In total, the company now has information for 5.6mln patients.
Drayson says the most important thing is the insights which improve patients' care, 'being able to identify the risk factors which enable doctors to better predict stroke and therefore be able to improve the care of the patient's who have had stroke'.
As well as analysis on patients who suffer with heart failure to better personalise their treatment and more recently working on Covid-19 patients, 'to detect lung disease related to Covid-19 infections'.
